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Technologies, Cleveland, Ohio.BACKGROUND Localizing the origin of outﬂow tract ventricular
tachycardias (OTVT) is hindered by lack of accuracy of electrocardio-
graphic (ECG) algorithms and infrequent spontaneous premature
ventricular complexes (PVCs) during electrophysiological studies.
OBJECTIVES To prospectively assess the performance of non-
invasive electrocardiographic mapping (ECM) in the pre-/peripro-
cedural localization of OTVT origin to guide ablation and to compare
the accuracy of ECM with that of published ECG algorithms.
METHODS Patients with symptomatic OTVT/PVCs undergoing clin-
ically indicated ablation were recruited. The OTVT/PVC origin was
mapped preprocedurally by using ECM, and 3 published ECG
algorithms were applied to the 12-lead ECG by 3 blinded electro-
physiologists. Ablation was guided by using ECM. The OTVT/PVC
origin was deﬁned as the site where ablation caused arrhythmia
suppression. Acute success was deﬁned as abolition of ectopy after
ablation. Medium-term success was deﬁned as the abolition of
symptoms and reduction of PVC to less than 1000 per day
documented on Holter monitoring within 6 months.
RESULTS In 24 patients (mean age 50  18 years) recruited ECM
successfully identiﬁed OTVT/PVC origin in 23/24 (96%) (right
ventricular outﬂow tract, 18; left ventricular outﬂow tract, 6),
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1547-5271/ B 2014 Heart Rhythm Society. Open access under CC BY-NC-ND license.success was achieved in 100% of the cases with medium-term
success in 22 of 24 patients. PVC burden reduced from 21,837 
23,241 to 1143 4039 (Po .0001). ECG algorithms identiﬁed the
correct chamber of origin in 50%–88% of the patients and
sublocalized within the right ventricular outﬂow tract (septum vs
free-wall) in 37%–58%.
CONCLUSIONS ECM can accurately identify OTVT/PVC origin in the
left and the right ventricle pre- and periprocedurally to guide catheter
ablation with an accuracy superior to that of published ECG algorithms.
KEYWORDS Ventricular tachycardia; Premature ventricular complex;
Outﬂow tract tachycardia
ABBREVIATIONS CT ¼ computed tomographic; EF ¼ ejection
fraction; ECG ¼ electrocardiographic; ECM ¼ electrocardiographic
mapping; EPS ¼ electrophysiological study; LV ¼ left ventricular/
ventricle; LVOT ¼ left ventricular outﬂow tract; OTVT ¼ outﬂow
tract ventricular tachycardia; PVC¼ premature ventricular complex;
PVS¼ programmed ventricular stimulation; RV¼ right ventricular/
ventricle; RVOT ¼ right ventricular outﬂow tract; VT ¼ ventricular
tachycardia
(Heart Rhythm 2014;11:587–594) I 2014 Heart Rhythm Society.
Open access under CC BY-NC-ND license.Introduction
Outﬂow tract ventricular tachycardia (OTVT) or frequent
premature ventricular complexes (PVCs) often occur in theabsence of structural heart disease and account for 10% of all
ventricular tachycardia (VT).1,2 The majority of these
originate from the right ventricular outﬂow tract (RVOT)
and the remainder from the left ventricular outﬂow tract
(LVOT), including the cusps of the aortic valve.3 Catheter
ablation within these complex anatomical structures can be
effective in eliminating symptoms and reversing PVC-
induced cardiomyopathy, but there remain signiﬁcant limi-
tations to current mapping techniques, including poor spatial
resolution of pace mapping, inaccurate localization of VT
origin based on electrocardiographic (ECG) algorithms, and,
especially limiting, lack of spontaneous ectopy rendering
activation mapping ineffective.4–6http://dx.doi.org/10.1016/j.hrthm.2014.01.013
Figure 1 A: ECMmethod of localization of ectopy origin.B: ECMpotential
maps of RVOT and LVOT ectopy. The images show the ECM potential PVC
map from the cranial and LAO views at 3 time points: T1, initiation of epicardial
breakthrough, and 2 later time points (T2 and T3). Top: After epicardial breakout
in the septal groove, the ensuing activation spreads directly anteriorly toward the
RV, suggesting RVOT origin. The successful ablation site here was in the mid-
septal RVOT. Bottom: After epicardial breakout in the septal groove, the
ensuing activation spreads posteriorly toward the LV, favoring the left ventricle.
The successful ablation site here was in the anterolateral LVOT. CRA¼ cranial;
ECM ¼ electrocardiographic mapping; LAD ¼ left anterior descending; LAO
¼ left anterior oblique; LV ¼ left ventricle; LVOT ¼ left ventricular outﬂow
tract; PVC ¼ premature ventricular complex; OT ¼ outﬂow tract; RV ¼ right
ventricle; RVOT ¼ right ventricular outﬂow tract.
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noninvasive technique providing global electroanatomical
maps of both ventricular chambers by projecting 252 body
surface electrode signals onto the epicardial geometry of the
heart derived from a noncontrast thoracic computed tomo-
graphic (CT) scan.7 This technology has the advantage of
being able to display the onset and electrical propagation of a
single PVC, recorded preprocedurally, onto the biventricular
geometry to guide ablation.
The objectives of this prospective study are 2-fold: ﬁrst, to
compare the accuracy of noninvasive ECM with that of
validated ECG algorithms in localizing OTVT origin pre-
procedurally, and second, to assess the periprocedural
capabilities of ECM as a novel mapping tool to guide
ablation of OTVT.
Methods
Study population
Patients undergoing clinically indicated ablation for symp-
tomatic PVCs or asymptomatic but frequent (Z10,000/24 h)
PVCs with an inferior axis on the 12-lead ECG were
prospectively recruited into the study. In addition, patients
with asymptomatic and/or infrequent PVCs in the presence
of idiopathic globally impaired left ventricular (LV) function
were included. All patients gave written informed consent
before the procedure. Local research ethics committee
approval was granted for the study.
Preprocedural mapping using ECM
Antiarrhythmic drugs were discontinued at least 5 half-lives
before the procedure. The ECM system has been described
previously.7–9 Brieﬂy, it consists of a 252-electrode vest
applied to the patient’s torso, acquiring electrical data at
2 kHz. After vest application, patients undergo noncontrast
thoracic CT scans with an axial resolution of 3 mm. The 252
body surface electrodes and epicardial surface geometry are
spatially labeled and deﬁned from CT images. These body
surface signals and geometric data are integrated to construct
3-dimensional electroanatomical maps composed of more than
1500 unipolar epicardial signals. These data are then applied
to an algorithm to localize the origin of ectopy (Figure 1A).
Following the CT scan, patients can ambulate with the vests,
which, in our study, were applied from up to 5 hours before the
procedure until the ablation was completed. ECM mapping
was performed with the patient in a recumbent position.
Three types of electroanatomical maps are generated by
ECM: potential, activation, and voltage maps (Figures 1 and 2).
The potential map is a dynamic map that displays global
propagation of the depolarization wave front, detected by the
earliest QS over the chosen cardiac interval (Figure 1B and
Online Supplemental Video 1).
The activation map is a static map displaying the
activation sequence across a chosen cardiac interval. The
map assigns an activation time to each unipolar electrogram
on the epicardial geometry (Figure 2). Activation calcula-
tions are computed from both the signal’s maximumnegative change of voltage (dV/dT) and the signal
morphology of neighboring electrograms. The activation
sequence is represented on the map by the color red as early
Figure 2 ECM pacing spike voltage maps and activation maps. Left panel: Potential map of clinical PVC initiation (top) and activation map of biventricular
global activation (below). Middle and right panels: Pacing spike voltage (top) and activation (bottom) maps created from mid-septal RVOT and anterolateral
LVOT pacing, respectively. Despite the close anatomical proximity of the 2 pacing sites (red dot), the global activation demonstrates a clear difference, allowing
localization of ectopy to the anterolateral LVOT. See accompanying supplementary videos. ECM¼ electrocardiographic mapping; LAO¼ left anterior oblique;
LVOT ¼ left ventricular outﬂow tract; PA ¼ posteroanterior; PVC ¼ premature ventricular complex; RVOT ¼ right ventricular outﬂow tract.
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electrogram.
The voltage map displays the signal amplitude at each
point on the epicardial geometry over the selected interval
(white represents high amplitude and red represents low
amplitude). As the system is unable to track the catheter
location in real time, a voltage map of the pacing spike
(pacing spike voltage map) can localize the pacing stimulus
as a surrogate marker for catheter location (displayed as a red
dot on the map in Figure 2).
All clinical VT/PVC morphologies were captured by the
system and processed to display a potential and an activation
map. The origin of the PVC was localized by the ECM
system to 1 of 12 segments in the RVOT (high/low;
posteroseptal/midseptal/anteroseptal/posterior free wall/
anterior free wall/mid free wall of the RVOT) and 1 of 5
segments in the LVOT (noncoronary cusp/right coronary
cusp/left coronary cusp/aortomitral continuity/septal LVOT).
When clinical PVCs were captured preprocedurally, these
maps were generated before the patient entered the electro-
physiology laboratory. PVCs of the highest frequency were
deemed to be of most clinical relevance.Electrophysiological study
Venous access was obtained from the right femoral veins
(8- and 6-F sheaths), and arterial access was obtained from
the right femoral artery (8 F) for hemodynamic monitoringand retrograde access to the LVOT. A pentapolar catheter
was inserted under ﬂuoroscopic guidance via the femoral
venous sheath into the right ventricular (RV) apex for
pacing and to act as an intracardiac activation reference.
A standard 4-mm nonirrigated tip ablation catheter
(eg, Biosense Webster Inc, Diamond Bar, CA) was used.
A maximum power delivery of up to 50 W with a
maximum temperature limited to 60ºC was used for the
RVOT and the LVOT. Left-sided mapping was performed
via the retrograde aortic approach with systemic heparin-
ization, targeting serial activated clotting time (ACT)
values of greater than 300 seconds.
Spontaneous clinical PVCs captured periprocedurally
were cross-referenced with PVCs captured preprocedurally
on ECM to conﬁrm a match. The 12-lead ECG of the clinical
VT/PVC was displayed on a recording system (Bard
Labsystem Pro, Bard Electrophysiology Division, Lowell,
MA) as a template for pace mapping. If no spontaneous
PVCs were present, programmed ventricular stimulation
(PVS) was performed by pacing at twice the diastolic
threshold and pulse width of 2 ms from the RVA and the
RVOT at 2 drive cycle lengths with up to 3 extrastimuli with
or without isopretenerol.
After the ECM identiﬁcation of the PVC origin, the
ablation catheter was ﬂuoroscopically guided to perform
pace mapping at various sites within the segment of interest
containing the PVC origin as identiﬁed by the ECM system.
At each site, pacing was performed to create ECM maps and
Heart Rhythm, Vol 11, No 4, April 2014590the ablation site was identiﬁed if it fulﬁlled the following
criteria:1. the resultant potential and activation maps corresponded
with those during the clinical VT/PVC and2. the catheter location on the voltage map corresponded
anatomically with the earliest site of electrical activation
during VT/PVC (Figure 2).
At this location, the match of the pace map on the 12-lead
ECG to the clinical VT/PVC and the prematurity of local
activation as recorded by the distal bipole of the ablation
catheter in relation to QRS onset during spontaneous VT/
PVC also measured and documented.
After ablation at the site identiﬁed by ECM mapping, if
spontaneous ectopy was still evident then operator discretion
was used to continue mapping using ECM or conventional
criteria.
The PVC origin was deﬁned by the site at which ablation
resulted in loss of spontaneous ectopy or if ablation resulted
in noninducibility.
The successful site of ablation was stored as standard
ﬂuoroscopic right anterior oblique and left anterior oblique
views. Acute procedural success was deﬁned as the absence,
or noninducibility, of the targeted VT/PVC during a 20-
minute observation period with repeated PVS after delivery
of the last ablation lesion.
ECG algorithms to identify VT origin
We hypothesized that ECM would be superior to validated
ECG algorithms at localizing VT origin. The V2 transition
ratio (algorithm B) published by Betensky et al10 localizes
ectopy origin to either the LV or the RV. Zhang et al11
(algorithm A) and Ito et al12 (algorithm C) published criteria
that allow further sublocalization within the RV (septum vs
free-wall). To assess ECG accuracy at PVC localization, 3
electrophysiologists blinded to the ECM data and ablation
outcomes applied these 3 algorithms retrospectively to the
same 12-lead ECGs of clinical VT/PVC. The intra- and
interobserver variability was also tested. All ECGs were
digitalized, and durations and amplitudes were measured at a
magniﬁcation of 200. One month after the ﬁrst round of
analysis, the same set of ECGs were reanalyzed by the same
electrophysiologists. The performance of ECM and 3 ECG
algorithms was determined to identify the site of successful
ablation.
Follow-up
Antiarrhythmic medications were not resumed in all patients
after ablation. β-Blockers were continued, if required, for
other clinical indications. All patients underwent echocar-
diography before ablation, and those with impaired LV
function or a postablation PVC burden of 10,000/24 h
underwent a repeat scan postablation. Patients were reviewed
in the arrhythmia clinic 3–6 months after the procedure, and
each patient underwent a clinical interview to assesssymptomatology, 12-lead ECG, and 24-hour Holter mon-
itoring. Arrhythmia recurrence was deﬁned as symptomatic
recurrence with documented clinical arrhythmia or PVC
burden exceeding 1000 in 24 hours on Holter monitoring.
Symptoms were classiﬁed into 4 categories; complete
absence, signiﬁcantly improved, unchanged, or worsened.
Statistical analysis
Continuous variables are expressed as mean  SD. Catego-
rical variables were compared by using the Wilcoxon signed-
rank test. The free marginal multi-rater kappa was used to
assess the chance-adjusted measure of agreement between
electrophysiologists analyzing the ECGs using 3 different
algorithms. The kappa coefﬁcient was also used for intra-
rater agreement testing. Statistical analysis was performed by
using SPSS statistical software (release 21.0, SPSS, Chicago,
IL). A P value of r.05 was considered statistically
signiﬁcant. A kappa value of Z0.7 indicated adequate
agreement above chance.
Results
Effectiveness of ECM at localizing VT/PVC origin
Twenty-four clinical VT/PVC morphologies (23 with left
bundle branch block) were targeted in 24 patients (8 men;
mean age 50  18 years). In 21 of 24 patients with
spontaneous PVC/VT preprocedurally, the PVC origins
could be located on the ECM geometry before electro-
physiological study (EPS). In the remaining 3 patients, ECM
located the PVC origin periprocedurally. In all but one
patient, PVCs occurred spontaneously or with the initiation
of isoproterenol infusion. In only 1 patient was PVS useful
for PVC induction.
The ﬁrst ablation lesion was delivered at all 24 sites
identiﬁed by pre-/periprocedural ECM, which resulted in
acute procedural success in 23 of 24 patients. The local
bipolar electrogram at these sites during clinical ectopy pre-
ceded VT/PVC QRS onset by 29  9 ms (range 10–45 ms).
At 22 of 24 sites, a 12/12 pace match was achieved. The best
pace map at the remaining 2 sites was 11/12 and 10/12.
The mean number of ablation lesions, including consol-
idation lesions, was 7.5  7 before PVC quiescence.
Of interest was patient 11 (see case study 1 in the Online
Data Supplement), who demonstrated not only the limitation
of conventional mapping but where all 3 ECG algorithms,
applied by all assessors, located the site of origin in the
incorrect chamber.
ECM failed to identify the appropriate site of ablation in a
single case (patient 19), where the origin of a left bundle
branch block PVC with QRS transition at lead V3/V4 was
localized by the ECM to the RVOT. However, at this site,
“His” bundle capture was noted with an 11/12 ECG pace-
map match and local activation which preceded QRS onset
by 40 ms. Ablation was commenced at low-power settings
and was stopped early owing to the occurrence of a single
nonconducted sinus beat. Pacing in the surrounding RVOT
region did not reproduce the clinical PVC ECM activation
Table 1 Accuracy of ECM with successful ablation site
Patient
Successful
ablation
site
ECM
location
ECG
pace-
map
match
Endocardial
earliest local
activation
timing
(pre-QRS)
1 RVOT RVOT 12 36
2 RVOT RVOT 12 14
3 AMC AMC 12 38
4 RVOT RVOT 12 28
5 RVOT RVOT 12 NA
6 AMC AMC 12 10
7 RVOT RVOT 12 40
8 RVOT RVOT 12 28
9 RVOT RVOT 12 36
10 LCC LCC 12 28
11 LCC LCC 11 34
12 RVOT RVOT 12 22
13 RVOT RVOT 10 22
14 RVOT RVOT 12 36
15 RVOT RVOT 12 40
16 LVOT LCC 12 30
17 RVOT RVOT 12 35
18 RVOT RVOT 12 28
19 RVOT/NCC RVOT near
His
12 45
20 RVOT RVOT 12 40
21 RVOT RVOT 12 20
22 RVOT RVOT 12 28
23 RVOT RVOT 12 26
24 RVOT RVOT 12 30
Correct diagnosis 23/24
Diagnostic accuracy 96%
AMC ¼ aortomitral continuity; ECM ¼ electrocardiographic mapping;
LCC ¼ left coronary cusp; LVOT ¼ left ventricular outﬂow tract; NCC ¼
noncoronary cusp; RCC ¼ right coronary cusp; RVOT ¼ right ventricular
outﬂow tract.
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created in the LVOT identiﬁed a perfect match at the region
between the right coronary cusp and the noncoronary cusp
with an early local electrogram (45 ms) and a 12/12 pace-
map match. Fluoroscopically this site was anatomically
adjacent to the RVOT site explored earlier.
Acute procedural success was achieved in all patients
after ablation at 18 RV and 6 LV sites: 3 posteroseptal
RVOT, 8 anteroseptal RVOT, 4 mid-septal RVOT, 2
posterolateral RVOT, 4 left coronary cusp, 1 noncoronary
cusp/right coronary cusp junction, and 2 aortomitral con-
tinuity sites. The mean power delivered was 37  13 W.
Six patients had previously undergone EPS; 3 having had
unsuccessful ablation. One patient with recurrent symptoms
had undergone 4 attempts at ablation, but on each previous
occasion, ablation could not be completed owing to lack of
spontaneous clinical ectopy.
ECG algorithms vs ECM at localizing VT/PVC origin
ECM predicted the correct ventricular chamber (left vs right)
in 96% of the cases (Table 1). In 23 of 24 cases in which
ECM predicted the correct ventricular chamber, the correct
region within that chamber was sublocalized in 100% of the
cases.
The diagnostic accuracy of ECGs analyzed retrospec-
tively by 3 independent electrophysiologists for LVOT vs
RVOT varied from 79% to 88% using algorithm A, from
67% to 71% using algorithm B, and from 50% to 63% using
algorithm C. The correct sublocalization of ectopy origin
within the RVOT septum vs RVOT free wall using algo-
rithms A and C varied from 37% to 58% and from 37% to
53%, respectively (Table 2).
The inter-rater agreement for ECG analysis was measured
for localization to the RVOT septum, RVOT free wall, or LV
using ECG algorithms A and C and for RV vs LV for
algorithm B. Free marginal kappa values of 0.15 (overall
agreement of 43%) and 0.54 (overall agreement of 69%)
were obtained for ECG algorithms A and C, respectively,
conﬁrming poor inter-assessor agreement. An acceptable
kappa value of 0.72 was obtained for algorithm B with 86%
overall agreement.
Intraobserver agreement testing performed within
3 months of the initial ECG analyses reproduced similar
results (Table 3).
Clinical outcomes
All patients experienced signiﬁcant improvement in symp-
toms in the immediate postoperative period. Twenty-one
patients were completely symptom-free or experienced
symptomatic improvement with signiﬁcant reduction in
OTVT/PVC burden over a mean follow-up duration of
11  4 months (from 21,837  23,241 to 1143  4039;
Z ¼ 4.286; P o .0001).
Three patients reported recurrence in symptoms or
worsening of symptoms during extended follow-up. Two
of these 3 patients had repeated Holter ECGs, whichdocumented a signiﬁcant reduction in ectopy. In patient 9,
clinical ectopy was reduced from 500 to less than 40 per day.
In patient 21, symptoms recurred 3 weeks. Holter monitoring
showed a sustained PVC reduction from 14,000 to 4700.
Patient 8 had recurrence of frequent PVCs, which were from
3 distinctly different origins and were successfully ablated
during repeat ablation.
The mean LV ejection fraction (EF) for the group was
57%  11%. Four patients were found to have moderate to
severe impairment of LV systolic function (EF 37.8% 
10.5%; PVC burden 22,045  15,057 in 24 hours). Repeat
scans after ablation in this cohort did not show signiﬁcant
improvement in the LV EF (39%  22%; PVC burden
5444  9842). One of these patients has been discussed
previously (patient 8).Prior failed procedures
Six patients had previously attended for 9 attempted abla-
tions collectively, which were either unsuccessful or aborted
owing to lack of spontaneously occurring clinical PVCs.
One patient with a previously abandoned study due to
noninducibility did not have any spontaneous PVCs during
Table 2 (A) ECG localization of ectopy origin between the RV and
the LV using algorithms A–C and (B) sublocalization in the RVOT
(septum vs free-wall) using algorithms A and C, compared with
successful ablation site, as tested by 3 independent assessors
Accuracy of ECG Algorithms in localising within
the LVOT vs RVOT
Algorithm A Algorithm B Algorithm C
Assessor 1 79% 67% 50%
Assessor 2 88% 67% 63%
Assessor 3 83% 71% 58%
Accuracy of ECG Algorithms in sub-localising
within the RVOT: septum vs free-wall
Algorithm A Algorithm C
Assessor 1 42% 37%
Assessor 2 58% 53%
Assessor 3 37% 42%
ECG ¼ electrocardiographic; LV ¼ left ventricle; RV ¼ right ventricle;
RVOT ¼ right ventricular outﬂow tract.
Table 3 Intraobserver agreement was tested by using the kappa
coefﬁcient for all 3 ECG algorithms on all 24 ECGs of clinical PVC by 2
independent assessors
Intra-observer ECG agreement
Algorithm A Algorithm B Algorithm C
Assessor 2 0.85 1 0.80
Assessor 3 0.87 0.62 1
ECG ¼ electrocardiographic; PVC ¼ premature ventricular complex.
Heart Rhythm, Vol 11, No 4, April 2014592the preprocedural mapping period. Single beats of the
clinical arrhythmia could be consistently induced at the
end of each drive train during PVS. These PVCs were
sufﬁcient for the ECM to localize the arrhythmia origin to
guide successful ablation (see case study 2 in the Online Data
Supplement).
All 6 patients were successfully treated by using ECM.
PVC burden on Holter monitoring for this cohort was reduced
from 14,672  16,969 to 10  16 per 24 hours (P o .05)
during a mean follow-up duration of 13  3 months.
Discussion
Pre- and periprocedural mapping using ECM successfully
identiﬁes the OTVT/PVC origin to guide ablation, even in
patients with minimal ectopy at the time of ablation.
Limitations of conventional intraprocedural
localization of ectopy origin
During the EPS, the origin of ectopy is localized by pace
mapping in regions of interest on the basis of analysis of the
12-lead ECG during OTVT/PVC, with the aim of achieving
an exact 12-lead match with spontaneous OTVT/PVC.13
However, pace mapping can be imprecise with exact matches
achieved from pacing sites more than 2 cm away from the
origin of PVC.14,15 Activation mapping using unipolar and
bipolar electrograms can also be used to corroborate the pace-
map ﬁndings in patients with frequent OTVT/PVCs. How-
ever, the mean area of myocardium activated within the ﬁrst
10 ms during RVOT VT can range from 1.3 to 6.4 cm2. This,
along with an interobserver variability of up to 5 ms or more
in the manual assignment of activation time, is a signiﬁcant
limitation of activation mapping.14,15
In addition, sequential activation mapping, with or with-
out 3-dimensional electroanatomical navigation systems, is
heavily dependent on sufﬁcient spontaneous or inducedclinical ectopy. As seen in 1 patient in our series, attempts
to localize and ablate VT origin were abandoned during 4
previous procedures owing to minimal spontaneous ectopy
despite pacing maneuvers and pharmacological adjuvants.
The limitations of both activation and pace mapping were
clearly illustrated in patient 11 (see case study 1 in the Online
Data Supplement).
These disadvantages can be overcome by the use of an
invasive noncontact mapping Ensite array that allows for
mapping of single beats of ectopy. However, it requires
systemic heparinization, even in the RV, increasing the risk
of bleeding complications. Furthermore, only a single
chamber can be mapped at a time. ECM overcomes these
2 limitations and even allows the patient to remain ambula-
tory for several hours before the EPS to allow spontaneous
arrhythmia to be recorded without prolonging invasive
procedural time.
The ability to predict left-sided arrhythmia from right-sided
arrhythmia could better guide informed consent with regard to
procedural time and risk, although complete certainty is still
not possible with current noninvasive systems.
Limitations of 12-lead ECG localization
of ectopy origin
The ability to predict left-sided arrhythmia from right-sided
arrhythmia is of great importance as it guides informed consent
with regard to procedural time and risk. The 12-lead ECG of
OTVT/PVC is conventionally used preprocedurally for this
purpose to plan access (ie, RV vs LV) and ablation strategy.
ECG criteria have been extensively published, describing
characteristics of ectopic foci originating from the RVOT,
the LVOT, and the aortomitral continuity, anterior interven-
tricular vein, and the aortic sinus cusps.10–12,16,17
The V2 transition ratio (algorithm B) correctly predicted
LVOT vs RVOT origin in 91% of the cases in their study.10
In our cohort, the algorithm was correct in 67%–71% of the
patients when applied by 3 independent electrophysiologists
with an acceptable inter-rater kappa agreement value of 0.72.
Algorithms A and C not only differentiate LVOT from
RVOT origin but also sublocalize within the RVOT, with
published sensitivity, speciﬁcity, and positive predictive
values ranging from 70% to 90%. However, the application
of the protocols in our cohort yielded the correct location
(RV free-wall vs RV septum vs LV) in only 46%–63% of the
cases, with poor interobserver agreement kappa values of
0.15 and 0.54.
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tion, there are an increasing number of steps and measure-
ments required to reach a diagnosis, thus increasing the
chances of error and variability in results. We observed that
the reduction in the reliability of each algorithm was
proportional to the number of steps needed to reach a
diagnosis. Algorithm B, involving 3 steps and localizing
between the RVOT and the LVOT, yielded an acceptable
result, with 86% overall agreement between the 3 assessors.
However, algorithm A, involving 5 steps and sublocalizing
to 8 regions (LV, near His, RV: anteroseptal, posteroseptal,
mid-septal, anterolateral, posterolateral, and mid-lateral),
yielded only 43% overall agreement between assessors.
These algorithms rely on measurements of parameters,
including amplitude of the S wave in lead V6, ratio of PVC
QRS duration to preceding sinus rhythm QRS duration, R/S-
wave amplitude ratio and R-wave duration index, which
can be prone to errors from a wandering baseline, lead noise,
and absence of a suitable sinus rhythm beat preceding the
PVC QRS, all of which are encountered in day-to-day
clinical practice. In addition, interpretation and measurement
of such parameters are inconsistent when performed on a
12-lead ECG at 25-mm speed in the absence of elec-
tronic calipers.
One striking example of ambiguity in such measurements
is the presence or absence of an S wave in lead V640.1 mV,
which is the ﬁrst step in algorithm C. We demonstrated a
consistent disagreement between the assessors across several
ECGs, with a poor inter-rater kappa agreement of 0.4 for this
parameter alone. Two ECG examples are shown in Online
Supplemental Figure 3. Similar variations were noted from
measurements made for other ratios and indices mentioned
above.
Further inaccuracies in ECG algorithms are introduced by
individual variability in the spatial relationship between the
heart, thoracic wall, and overall body habitus across patients.
This is taken into account by the ECM system owing to its
use of true cardiac anatomy from segmented CT geometry,
making it highly accurate at localization even in the presence
of underlying structural cardiac abnormalities. An additional
strength of the system is that the high-density ECM vest is
registered to the patient’s individually segmented CT geom-
etry, which removes the potential for ECG lead-placement
errors. The ECM vest can be applied at a time and location
remote to the ablation procedure and catheter laboratory in
which maneuvers to induce ectopy, including aerobic
exercises on the treadmill, can be performed for preproce-
dural mapping. To avoid any potential shifts in geometry,
ECM maps after exercise were created with the patient in the
recumbent position.
By overcoming the aforementioned limitations, ECM
accurately identiﬁed OTVT/PVC origin in the LV and
correctly sublocalized in each chamber in all patients.
Study limitations
A limitation of this study is the small patient group, which
does not cover the full spectrum of possible idiopathic OTVTlocations; however, as a proof of concept, it demonstrates the
feasibility and accuracy of ECM at pre- and periprocedural
localization of the OTVT/PVC origin even in patients with
minimal ectopy burden. In 3 of 24 patients, the clinical PVC
did not occur spontaneously during the preprocedural map-
ping period, which precluded preprocedural identiﬁcation of
the PVC origin. However, it is possible that an extended
period of vest wearing or the use of isopretenerol infusion
could increase the likelihood of recording the clinical PVC.
It is also important to acknowledge that the cardiac
vectors are projected onto the epicardial shell, although this
did not appear to affect the high ablation success rate.
Inability to track the ablation catheter or perform distance
measurements on the geometry limits testing of the system’s
resolution (within millimeters) of ﬁne localization of arrhyth-
mia origin and successful ablation site for comparison.
The need for CT scanning and associated radiation
exposure using ECM (mean 148 mGy  cm) should be
weighed against the beneﬁts of accurate localization of
ectopy origin and potential reduction in procedural and
ﬂuoroscopic time, which warrant further studies.
Conventional catheter ablation of PVCs with unambig-
uous localization from the ECG and frequent intraprocedural
ectopics is typically straightforward and associated with
excellent clinical outcomes. However, the use of the ECM
system may be particularly beneﬁcial in guiding more
challenging cases, such as patients with infrequent PVC
burden and multiple PVC morphologies.
Conclusions
Noninvasive ECM can accurately identify VT origin in both
LVOT and RVOT pre- and periprocedurally to guide
catheter ablation with an accuracy superior to that of
established ECG algorithms.
Appendix
Supplementary data
Supplementary data associated with this article can be found
in the online version at http://dx.doi.org/10.1016/j.hrthm.
2014.01.013.References
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